Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,525 recalls · Class III, newest first

Class III · Low risk

Introvale (levonorgestrel and ethinyl estradiol)

Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card

Terminated Labeling / mix-up Sandoz Incorporated NDC 0781-5584-36 D-854-2013
Class III · Low risk

Maalox

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-907-2013
Class III · Low risk

Maalox Extra Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-906-2013
Class III · Low risk

Maalox Regular Strength Antacid

Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.

Terminated Labeling / mix-up Novartis Consumer Health D-903-2013
Class III · Low risk

Clobetasol Propionate Cream

Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP. The actual product in the tube is Clobetasol Propionate Cream USP

Terminated Labeling / mix-up Hi-Tech Pharmacal Co., Inc. NDC 50383-267-15 D-888-2013
Class III · Low risk

Tagitol V Barium Sulfate Suspension

Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.

Terminated Stability / shelf life Bracco Diagnostics Inc NDC 32909-814-53 D-914-2013
Class III · Low risk

Oxycodone and Acetaminophen Capsules

Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.

Terminated Wrong potency / content Watson Laboratories Inc NDC 0591-0737-01 D-823-2013
Class III · Low risk

Tums

Presence of Foreign Tablets/Capsules: Product labeled TUMS Ultra Assorted Berries 1000mg Chewable tables, may contain EX TUMS Assorted Berries 750mg tablets

Terminated Particulate / foreign matter GlaxoSmithKline, LLC. NDC 0135-0181-02 D-850-2013
Class III · Low risk

Alcohol Free Antiseptic

Microbial Contamination of Non-Sterile Products: This product is being recalled because a stability sample was found to be contaminated with Burkholderia contaminans.

Terminated Microbial contamination Vi-Jon, Inc. D-812-2013
Class III · Low risk

Nata Komplete

Subpotent; Beta carotene (Vitamin A)

Terminated Wrong potency / content Stayma Consulting Service, LLC. NDC 76331-909-30 D-900-2013
Class III · Low risk

Duet DHA 430

Subpotent; Beta carotene (Vitamin A)

Terminated Wrong potency / content Stayma Consulting Service, LLC. NDC 76331-808-30 D-898-2013
Class III · Low risk

NataChew

Subpotent; Beta carotene (Vitamin A)

Terminated Wrong potency / content Stayma Consulting Service, LLC. NDC 44118-902-90 D-897-2013
Class III · Low risk

Duet DHA 400

Subpotent; Beta carotene (Vitamin A)

Terminated Wrong potency / content Stayma Consulting Service, LLC. NDC 44118-807-30 D-895-2013

Recalls by year